Among US adults, cardiovascular-kidney-metabolic syndrome disparities are affected by social risk profile. A key driver of cardiovascular-kidney-metabolic (CKM) syndrome disparities among adults in ...
OXM is studied as a potential once-daily treatment for patients with obesity, metabolic and fibrotic disorders. During an in vivo proof of concept study in rodent and pig models, the oral OXM ...